IS8328A - Pýrimidín afleiður til notkunar í meðferð á afbrigðilegum frumuvexti - Google Patents

Pýrimidín afleiður til notkunar í meðferð á afbrigðilegum frumuvexti

Info

Publication number
IS8328A
IS8328A IS8328A IS8328A IS8328A IS 8328 A IS8328 A IS 8328A IS 8328 A IS8328 A IS 8328A IS 8328 A IS8328 A IS 8328A IS 8328 A IS8328 A IS 8328A
Authority
IS
Iceland
Prior art keywords
treatment
cell growth
pyrimidine derivatives
aberrant cell
aberrant
Prior art date
Application number
IS8328A
Other languages
English (en)
Inventor
Charles Kath John
Joseph Luzzio Michael
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/005883 external-priority patent/WO2004056807A1/en
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS8328A publication Critical patent/IS8328A/is

Links

IS8328A 2003-09-05 2006-02-23 Pýrimidín afleiður til notkunar í meðferð á afbrigðilegum frumuvexti IS8328A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50074203P 2003-09-05 2003-09-05
PCT/IB2003/005883 WO2004056807A1 (en) 2002-12-20 2003-12-08 Pyrimidine derivatives for the treatment of abnormal cell growth

Publications (1)

Publication Number Publication Date
IS8328A true IS8328A (is) 2006-02-23

Family

ID=36758426

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8328A IS8328A (is) 2003-09-05 2006-02-23 Pýrimidín afleiður til notkunar í meðferð á afbrigðilegum frumuvexti

Country Status (2)

Country Link
IS (1) IS8328A (is)
NO (1) NO334841B1 (is)

Also Published As

Publication number Publication date
NO334841B1 (no) 2014-06-16
NO20061533L (no) 2006-05-24

Similar Documents

Publication Publication Date Title
IS7233A (is) Kínasólín afleiður til meðhöndlunar á afbrigðilegum frumuvexti
IS6616A (is) Setnar bísýklískar afleiður til meðhöndlunar á afbrigðilegum frumuvexti
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
IL173200A0 (en) Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
IS8267A (is) [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
IL174258A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
IL174261A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
IL174989A0 (en) 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
IS7858A (is) Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)
IL173380A0 (en) Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
NO20033635L (no) Pyrimidinderivater for inhibering av celle-formering
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DE60328735D1 (de) Chinazolinderivate
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DE602004004553D1 (de) Chinazolinderivate
DE602004022180D1 (de) Chinazolinderivate
PL1763517T3 (pl) Pochodne pirymidyny jako inhibitory 11BETA-HSD1
AP2241A (en) Pyrimidine derivatives for the treatment of abnormal cell growth.
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
DK1694122T3 (da) N-arylhydrazonderivater til fröbehandling
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
PL377686A1 (pl) Pochodne 4-anilinochinazoliny do leczenia anormalnego wzrostu komórek